©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Expression of ob Gene in Adipose Cells
REGULATION BY INSULIN (*)

(Received for publication, September 12, 1995; and in revised form, November 7, 1995)

Pascale Leroy (1) Sophie Dessolin (1) Phi Villageois (1) Byoung Chun Moon (2) Jeffrey M. Friedman (2) Gérard Ailhaud (2)(§) Christian Dani (1)

From the  (1)Centre de Biochimie (UMR 134 CNRS), Université de Nice-Sophia Antipolis, Faculté des Sciences, Parc Valrose, 06108 Nice cedex 2, France and (2)Howard Hughes Medical Institute, The Rockefeller University, New York, New York 10021-6399

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

The product of the recently cloned mouse obese (ob) gene is likely to play an important role in a loop regulating the size of the adipose tissue mass. The hormonal regulation of the ob gene could affect adiposity. To investigate this point, the effect of insulin on ob gene expression was examined in cells of the 3T3-F442A preadipocyte clonal line. ob mRNA is absent from exponentially growing, undifferentiated cells as well as from confluent preadipose cells. Terminal differentiation of preadipose to adipose cells leads to the expression of ob mRNA detected by a sensitive and quantitative ribonuclease protection assay. In adipose cells, the level of ob mRNA is sensitive to insulin in the nanomolar range of concentrations with an increase from an average of 1 copy to 5-10 copies/cell. The effect of insulin was fully reversible and takes place primarily at a transcriptional level. The ob mRNA shows a rapid turnover, with a half-life of approximately 2 h in the absence or presence of insulin. The level of secreted Ob protein is also regulated by insulin. These results indicate that the ob gene is expressed in mature fat cells only and support the possibility that insulin is an important regulator of ob gene expression.


INTRODUCTION

The ``lipostat'' or ``adipostat'' theory postulates that the size of body fat stores is regulated by a feedback loop(1) . This hypothesis is based upon the recovery of initial body weight following lipectomy (2) and parabiosis experiments between genetically obese and wild-type mice suggesting the existence of putative factor(s) regulating food intake(3) . The recently cloned ob gene from mouse, rat, and human encodes a circulating factor of 16 kDa that is secreted from adipocytes from various adipose depots(4, 5, 6, 7, 8) . The OB protein, named leptin, appears to act at a distant site since injections of the leptin decrease food intake and body weight in ob/ob mice and their lean counterparts(9, 10, 11, 12) . This phenomenon implicates directly or indirectly the hypothalamus since mice with chemical lesions of the ventromedial nucleus of the hypothalamus (VMH), (^1)after becoming rapidly hyperinsulinemic, express a dramatic increase in the levels of ob mRNA(5, 13) . A substantial fall in ob mRNA in the epididymal fat of lean mice has been observed after fasting; this phenomenon is rapidly reversed on refeeding(13, 14, 15, 16) . The correlation between insulin level and the levels of ob mRNA and plasma leptin suggests that insulin may have direct effects on ob gene expression(15, 16, 17, 18) . In this paper, we present data using cultured adipocytes that support this hypothesis.


EXPERIMENTAL PROCEDURES

Cell Culture

Culture conditions of cells of the 3T3-F442A clonal line have been described(19) . Cells were plated at 10^3 cells/cm^2 in 60- or 100-mm dishes and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. This medium was defined as standard medium. At confluence, standard medium was supplemented with 2 nM triiodothyronine (T(3)) and 3 nM insulin, termed differentiation medium, for 10 days. Media were changed every 2 days. Where indicated, insulin removal from 10-day postconfluent adipose cells was performed by rinsing the cells three times at 37 °C (20 min each) with DMEM containing 2% fetal bovine serum and 2 nM T(3). Insulin-deprived cells were then maintained for 24 h in standard medium supplemented with 2 nM T(3) before adding insulin at the indicated concentrations.

RNA Isolation

Total RNA was prepared as described by Chomczynski and Saachi(20) . At least two dishes were pooled for each condition. Northern blot analyses were performed as described previously(19) .

Ribonuclease Protection Assay

The EcoRI-PstI ob probe consisting of a 297-bp fragment starting 9 bp upstream of the first methionine codon was derived from mgt2b plasmid(4) . The template for in vitro transcription, which consists of the partial cDNA flanked with plasmid sequences, was prepared by gel purification of the fragment released by digestion with BssHII restriction enzyme. RNA probe was produced by T(3) RNA polymerase in the presence of [P]CTP (800 Ci/mmol, ICN France). The size of the probe was 365 nucleotides, and the size of the protected fragment was 297 bp. Used as an internal control, the GAPDH probe was synthesized from a construct provided by Dr. A. G. Smith (Edinburgh, UK). The RNA probe was produced by SP6 transcription. [P]CTP was diluted with unlabeled CTP in order to obtain a GAPDH probe of specific activity approximately 20-fold lower than that of the ob probe. The size of the probe was 235 bp and that of the protected fragment was 220 bp(21) . Ribonuclease protection assays were performed with 20-40 µg of RNA essentially as described previously(22) , except that hybridizations were done at 65 °C overnight. Protected species were resolved on a 6% acrylamide/urea gel and visualized by autoradiographic exposure on x-ray film (Kodak) at -70 °C for 5-7 days.

Estimation of the Number of ob Transcripts per Cell

The number of ob RNA/cell was determined by comparison with varying amounts of ob RNA synthesized in vitro. Briefly, ob sense RNA was produced by T7 transcription of the 297-bp fragment. The integrity and quantification of the product were confirmed by agarose gel electrophoresis and ethidium bromide staining. Quantification of the hybridization signal was performed using a PhosphorImager apparatus (Molecular Dynamics). As little as 0.1 pg of in vitro synthesized RNA could be detected under the conditions described above. This RNA has a molecular weight of approximately 105,000. Therefore, 0.1 pg corresponds to 6 times 10^5 molecules. Assuming a yield of 20 µg of RNA/10^6 cells, this corresponds, in a sample of 20 µg of total RNA, to the detection of one copy of ob RNA/cell.

Detection of Leptin in Conditioned Media

Differentiated 3T3-F442A cells were washed as described above and then maintained under serum-free conditions in H-16/F-12 medium (1:1, v/v) supplemented with 0.2 nM T(3), 20 nM sodium selenite, 10 µg/ml aprotinin, 2 µg/ml leupeptin, and 1 µg/ml pepstatin, in the absence or presence of insulin. Media were then collected and analyzed for leptin as described previously(10) .


RESULTS AND DISCUSSION

Expression of ob Gene during Differentiation of 3T3-F442A Cells

We have previously reported that ob mRNA is detected in the adipocyte fraction of mouse adipose tissues only(5) . The major, if not exclusive, expression of ob gene in the adipocyte was reminiscent of the expression of adipsin gene (19) and suggested that ob gene was a marker of terminally differentiated cells. This has been studied more directly during the differentiation of cells from the 3T3-F442A preadipocyte clonal line. Induction of ob gene expression was compared with that of adipsin gene and also with that of the alpha2 chain of type VI collagen (A2COL6) gene, a very early marker expressed before triacylglycerol deposition(23, 24) . The amount of A2COL6 and adipsin mRNA transcripts was determined by Northern blot analysis whereas the relatively low level of ob mRNA in cultured adipocytes necessitated the use of a highly sensitive ribonuclease protection assay. No expression of A2COL6, adipsin, and ob genes was observed in exponentially growing, undifferentiated cells (Fig. 1). A2COL6 gene was expressed at confluence, and a maximal level of A2COL6 mRNA was attained 2 days later a time at which no lipid droplets could yet be seen by microscopy examination. The kinetics of induction of adipsin and ob genes showed a similar time course. This relatively late expression followed the accumulation of small lipid droplets in a majority of cells between day 2 and day 4. Ten days after confluence, when the lipid accumulation was near maximal, the ob mRNA level reached 5-10 copies/cell (assuming it is evenly expressed in all cells) in the continuous presence of insulin. The removal of insulin led to a lower ob mRNA content (1 copy/cell, not shown). Under these conditions, as previously reported(19) , the content in beta-actin mRNA did not vary by more than ±5% whereas that in GAPDH mRNA did not vary by more than ±8%. Since an appropriate GAPDH riboprobe was readily available, the GAPDH mRNA content was used as an internal control. These results indicated that ob mRNA accumulated as a function of differentiation and suggested that insulin was involved in the regulation of ob gene expression.


Figure 1: Expression of ob mRNA during differentiation of 3T3-F442A cells. Cells were maintained from confluence in differentiation medium. Total RNAs were prepared at the indicated times. ob transcript has been determined using a ribonuclease protection assay. Expression of A2COL6 and adipsin transcripts have been determined by performing Northern blot analysis. An equivalent amount of intact RNA was run in each condition as indicated by hybridization to a GAPDH probe and beta-actin probe (not shown). The results are standardized to GAPDH mRNA signals and expressed by taking as 100% the maximal signal obtained for each probe. , A2COL6 mRNA; box, adipsin mRNA; up triangle, ob mRNA.



Effects of Insulin on ob Gene Expression and Leptin Secretion

In order to ascertain whether insulin had direct effects on ob gene expression, the levels of ob mRNA and leptin were measured in 10-day postconfluent, differentiated 3T3-F442A adipose cells. Insulin deprivation of differentiated cells for 24 h resulted in a dramatic decrease in ob mRNA content (Fig. 2). After insulin removal, the average number of ob transcripts was estimated to be one copy/cell and was similar to that determined in 10-day postconfluent cells never exposed to the hormone. The addition of insulin to insulin-deprived cells restored the steady-state level of ob mRNA to the starting level within 48 h. As shown previously(19) , insulin had an opposite effect on adipsin gene expression. The time course of insulin action on the steady-state level of ob mRNA in 10-day postconfluent, differentiated 3T3-F442A cells has also been determined. As shown in Fig. 3, the effect of insulin on the accumulation of ob RNA was not immediate. Insulin treatment led to a 3-fold increase in the ob RNA content within 10 h whereas a maximal 5-10-fold increase was obtained within 24 h. During the same period of time, insulin treatment led to a significant decrease of adipsin mRNA. The half-maximal effective concentration (EC) was estimated to be 0.3-1 nM (Fig. 4), in good agreement with the affinity of the insulin receptor for insulin in these cells and the EC values determined for the insulin effects on glucose and amino acid uptake(25) . Altogether, these results indicate that insulin has a reversible effect and is a potent modulator of ob gene expression in differentiated adipose cells. These results are also in agreement with the high level of ob mRNA observed in vivo in the hyperinsulinemic state in refed or VMH-lesioned mice(5) . In order to see whether insulin effects could also be detected at the protein level, analysis of leptin was performed from conditioned media of differentiated cells exposed or not to the hormone. As shown in Fig. 5, the amount of secreted leptin was greatly decreased when insulin was removed for 24 or 48 h (lanes 2 and 4 compared with lane 1). As anticipated, readdition of insulin to the insulin-deprived cells led to an increase of secreted leptin (lanes 3 and 5). No protein could be detected in the conditioned medium of undifferentiated cells exposed to insulin (lane 7) as well as from fresh serum-free (lane 6) or serum-containing medium (lane 8).


Figure 2: ob RNA content in 3T3-F442A adipose cells after insulin removal followed by insulin addition. Left panel: a, confluent cells were maintained for 10 days in differentiation medium; b, cells maintained as in a were treated to remove insulin as described under ``Experimental Procedures'' and then exposed to standard medium supplemented with 2 nM T(3) for 24 h; c, insulin-deprived cells obtained as in b were exposed to 3 nM insulin for 48 h. Total RNAs were prepared in each condition, and determination of ob and adipsin RNAs contents were performed as described in Fig. 1. Right panel, the results are standardized to GAPDH mRNA signals and expressed by taking as 100% the maximal signal obtained for each probe. , ob mRNA; box, adipsin mRNA.




Figure 3: Time course of insulin effect on ob RNA level in 3T3-F442A adipose cells. After 10 days in differentiation medium adipose cells were treated to remove insulin as described in Fig. 2. Then, 1 nM insulin (open symbols) or 3 nM insulin (black symbols) were added at time zero to standard medium containing 2 nM T(3). At the indicated times, RNAs were prepared and analyzed as described in Fig. 1. The results are standardized to GAPDH mRNA signals and expressed by taking as 100% the maximal signal obtained in each condition. up triangle, , ob mRNA; box, adipsin mRNA.




Figure 4: Dose-response relationship of insulin to ob RNA accumulation. Left panel, control cells (C) were maintained in differentiation medium for 10 days and analyzed for ob and GAPDH mRNA content using ribonuclease protection assays (6-day exposure time). In parallel experiments, control cells were treated to remove insulin (defined as condition 0) as described in Fig. 2, and insulin was added at various concentrations for 24 h. Probes (P) and protected fragments are indicated. Right panel, the results are standardized to GAPDH mRNA signals (12-h exposure time) and expressed by taking as 100% the stimulation observed at 3 nM insulin.




Figure 5: Secreted leptin in the absence or the presence of insulin. Twelve-day postconfluent, differentiated 3T3-F442A cells were maintained under serum-free conditions as described under ``Experimental Procedures.'' Leptin concentration was measured by immunoprecipitation in the presence or absence of insulin. Lane 1, 24-h protein expression in the presence of 3 nM insulin; lanes 2 and 4, expression after 24 and 48 h in the absence of insulin, respectively; lanes 3 and 5, 24-h expression after readdition of insulin (1 and 3 nM, respectively); lane 6, serum-free medium alone; lane 7, 24-h protein expression in the presence of 3 nM insulin in 2-day postconfluent, undifferentiated cells; lane 8, serum-containing medium alone.



Half-life of ob mRNA and Transcriptional Activation of ob Gene by Insulin

Previous data suggested that insulin resulted in transcriptional and post-transcriptional regulation of the expression of lipid-related genes in 3T3-F442A cells(19) . In order to delineate the mechanisms by which insulin regulates ob gene expression in differentiated adipose cells, the stability of ob mRNA was compared in the absence or the presence of insulin. The rapid decay of ob mRNA content after insulin removal (see Fig. 2) suggested a rapid turnover of ob mRNA. As shown in Fig. 6(upper panel), within 2 h following addition of actinomycin D, an inhibitor of transcription, the level of ob mRNA content decreased by approximately 50%. This decrease was similar in the absence or the presence of insulin. Therefore, ob mRNA has a half-life of approximately 2 h whereas insulin does not have any significant stabilizing effect. The lack of ob mRNA accumulation after adding insulin in cells preincubated with actinomycin D for 15 min indicated that insulin regulates the expression of the ob gene by means of transcriptional activation (Fig. 6, lower panel). The characterization of trans-acting factors recognizing insulin response element(s) of ob promoter has not yet been identified.


Figure 6: Half-life of ob mRNA and transcriptional activation of ob gene by insulin in adipose cells. Upper panel, postconfluent 3T3-F442A cells were maintained in standard medium containing 2 nM T(3) for 10 days and then supplemented (A) or not (B) with 10 nM insulin for 24 h (defined as time zero). Actinomycin D (2 µg/ml) was added for 2 h. The results are standardized to GAPDH mRNA signals (12-h exposure time) and expressed by taking as 100% the signal obtained in each condition of culture at time zero of the actinomycin treatment. Lower panel, cells were maintained for 10 days in differentiation medium (a) or in differentiation medium followed by insulin removal (b) as described in Fig. 2. Then 1 or 3 nM insulin were added for 15 h in the absence (c, d) or the presence (e, f) of 5 µg/ml actinomycin D. Analysis for ob and GAPDH mRNA using ribonuclease protection assays was then performed (7-day exposure time).



In conclusion, ob gene is expressed in adipose cells only, and its regulation is reversibly and exquisitely sensitive to insulin at physiological concentrations. Secreted leptin can be detected in conditioned media of differentiated cells exposed to the hormone, and its concentration is also modulated by insulin in a reversible manner. The low expression of ob gene in vitro compared with in vivo suggests that other factors are required for maximal expression. The identification of additional factors that regulate ob gene expression is under investigation. It also appears that glucocorticoids regulate ob gene expression in vivo(26) , but the pharmacological doses used in this study prevent any definite conclusion. Adipogenic factors other than insulin, which have been reported to trigger terminal differentiation of adipose precursor cells to adipose cells(27) , are likely to play a regulatory role in the expression of ob gene.


FOOTNOTES

*
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed. Tel.: 33-92-07-64-40; Fax: 33-92-07-64-42.

(^1)
The abbreviations used are: VMH, ventromedial nucleus of the hypothalamus; DMEM, Dulbecco's modified Eagle's medium; bp, base pair(s); A2COL6, alpha2 chain of type VI collagen; T(3), triiodothyronine; GAPDH, glyceraldehyde-phosphate dehydrogenase.


ACKNOWLEDGEMENTS

We thank Drs. A. G. Smith and R. Négrel for helpful discussions, Dr. Y. Lemarchand-Brustel for critical reading of the manuscript, and G. Oillaux for secretarial assistance.


REFERENCES

  1. Kennedy, G. C. (1953) Proc. R. Soc. Lond. B Biol. Sci. 140, 578-592
  2. Leibelt, R. A., Ichinoe, S., and Nicholson, N. (1965) Ann. N. Y. Acad. Sci. 131, 559-582 [Medline] [Order article via Infotrieve]
  3. Hervey, G. R. (1959) J. Physiol. (Lond.) 145, 336-352
  4. Zhang, Y., Proenca, P., Maffei, M., Barone, M., Leopold, L., and Friedman, J. M. (1994) Nature 372, 425-432 [CrossRef][Medline] [Order article via Infotrieve]
  5. Maffei, M., Fei, H., Lee, G. H., Dani, C., Leroy, P., Zhang, Y., Proenca, R., Negrel, R., Ailhaud, G., and Friedman, J. M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 6957-6960 [Abstract]
  6. Masuzaki, H., Ogawa, Y., Isse, N., Satoh, N., Okazaki, T., Shigemoto, M., Mori, K., Tamura, N., Hosoda, K., Yoshimasa, Y., Jingami, H., Kawada, T., and Nakao, K. (1995) Diabetes 44, 855-858 [Abstract]
  7. Ogawa, Y., Masuzaki, H., Isse, N., Okazaki, T., Mori, K., Shigemoto, M., Satoh, N., Tamura, N., Hosoda, K., Yoshimasa, Y., Jingami, H., Kawada, T., and Nakao, K. (1995) J. Clin. Invest. 96, 1647-1652 [Medline] [Order article via Infotrieve]
  8. Murakami, T., and Shima, K. (1995) Biochem. Biophys. Res. Commun. 209, 944-952 [CrossRef][Medline] [Order article via Infotrieve]
  9. Pelleymounter, M. A., Cullen, M. J., Baker, M. B., Hecht, R., Winters, D., Boone, T., and Collins, F. (1995) Science 269, 540-543 [Medline] [Order article via Infotrieve]
  10. Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R., Burley, S. K., and Friedman, J. M. (1995) Science 269, 543-546 [Medline] [Order article via Infotrieve]
  11. Campfield, L. A., Smith, F. J., Guisez, Y., Devos, R., and Burn, P. (1995) Science 269, 546-549 [Medline] [Order article via Infotrieve]
  12. Weigle, D. S., Bukowski, T. R., Foster, D. C., Holderman, S., Kramer, J. M., Lasser, G., Lotton-Day, C. E., Prunkard, D. E., Raymond, C., and Kuijper, J. L. (1995) J. Clin. Invest. 96, 2065-2070 [Medline] [Order article via Infotrieve]
  13. Frederich, R. C., Löllmann, B., Hamann, A., Napolitano-Rosen, A., Kahn, B. B., Lowell, B. B., and Flier, J. S. (1995) J. Clin. Invest. 96, 1658-1663 [Medline] [Order article via Infotrieve]
  14. Trayhurn, P., Thomas, M. E. A., Duncan, J. S., and Rayner, D. V. (1995) FEBS Lett. 368, 488-490 [CrossRef][Medline] [Order article via Infotrieve]
  15. MacDougals, O. A., Hwang, C. S., Fan, H., and Lane, M. D. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9034-9037 [Abstract]
  16. Saladin, R., De Vos, P., Guerre-Millo, M., Leturque, A., Girard, J., Staels, B., and Auwerx, J. (1995) Nature 377, 527-529 [CrossRef][Medline] [Order article via Infotrieve]
  17. Stephens, T. W., Basinski, M., Bristow, P. K., Blue-Valleskey, J. M., Burgett, S. G., Craft, L., Hale, J., Hoffmann, J., Hsiung, H. M., Krlauclunas, A., MacKellar, W., Rosteck, P. R., Jr., Schoner, B., Smith, D., Tinsley, F. C., Zhang, X. Y., and Helman, M. (1995) Nature 377, 530-532 [CrossRef][Medline] [Order article via Infotrieve]
  18. Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., Kern, P., and Friedman, J. M. (1995) Nat. Medicine 1, 1-7 [Medline] [Order article via Infotrieve]
  19. Dani, C., Bertrand, B., Bardon, S., Doglio, A., Amri, E. Z., and Grimaldi, P. (1989) Mol. Cell. Endocrinol. 63, 199-208 [Medline] [Order article via Infotrieve]
  20. Chomczynski, P., and Saachi, N. (1987) Anal. Biochem. 162, 156-159 [CrossRef][Medline] [Order article via Infotrieve]
  21. Robertson, M., Chambers, I., Rathjen, P., Nichols, J., and Smith, A. (1993) Dev. Genet. 14, 165-173 [Medline] [Order article via Infotrieve]
  22. Leroy, P., and DeRobertis, E. M. (1992) Dev. Dynamics 194, 21-32 [Medline] [Order article via Infotrieve]
  23. Dani, C., Doglio, A., Amri, E. Z., Bardon, S., Fort, P., Bertrand, B., Grimaldi, P., and Ailhaud, G. (1989) J. Biol. Chem. 264, 10119-10125 [Abstract/Free Full Text]
  24. Ibrahimi, A., Bertrand, B., Bardon, S., Amri, E. Z., Grimaldi, P., Ailhaud, G., and Dani, C. (1993) Biochem. J. 289, 141-147 [Medline] [Order article via Infotrieve]
  25. Karlsson, F. A., Grunfeld, C., Kahn, C. R., and Roth, J. (1979) Endocrinology 104, 1383-1392 [Medline] [Order article via Infotrieve]
  26. De Vos, P., Saladin, R., Auwerx, J., and Staels, B. (1995) J. Biol. Chem. 270, 15958-15961 [Abstract/Free Full Text]
  27. Ailhaud, G., Grimaldi, P., and Négrel, R. (1992) Annu. Rev. Nutr. 12, 207-233 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.